Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Contingent Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹10 Cr₹21 Cr₹16 Cr₹22 Cr₹13 Cr

What is the latest Contingent Liabilities ratio of GLAND PHARMA ?

The latest Contingent Liabilities ratio of GLAND PHARMA is ₹10 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹10 Cr
Mar2025₹21 Cr
Mar2024₹16 Cr
Mar2023₹22 Cr
Mar2022₹13 Cr

How is Contingent Liabilities of GLAND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2026 ₹10 Cr
-52.68
Mar2025 ₹21 Cr
37.24
Mar2024 ₹16 Cr
-29.41
Mar2023 ₹22 Cr
72.94
Mar2022 ₹13 Cr -

Compare Contingent Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹46,618.3 Cr -7.2% -3.1% 48.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹108,012.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-7.2%

-3.1%

48.9%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses